Literature DB >> 7675312

Morphological study of surgically induced open neural tube defect in old (14 and 21 days) chick embryos.

K B Sim1, B K Cho, J G Chi, K C Wang.   

Abstract

As an experimental model for the research of open neural tube defect (NTD), the surgical model has several advantages over others, in spite of the fact that the pathogenetic mechanism is not compatible with the human intrauterine events. To make reproducible NTDs by surgery and to compare the surgically induced lesions with the human myeloschisis morphologically, we opened the neural tube for a length of 9-11 somites in Hamburger and Hamilton stage 16-19 chick embryos. Embryos which survived until the late in ovo life (total age 14 and 21 days) showed relatively reproducible open NTDs. Morphologically they are similar to human myeloschisis. This study suggests that the surgical model can be suitable for studies of open NTDs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675312     DOI: 10.1016/0304-3940(95)11610-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

Review 1.  Experimental models of spinal open neural tube defect and Chiari type II malformation.

Authors:  Ki-Bum Sim; Ji Yeoun Lee; Ji Hoon Phi; Seung-Ki Kim; Kyu-Chang Wang
Journal:  Childs Nerv Syst       Date:  2013-09-07       Impact factor: 1.475

2.  Development of an experimental model of brain tissue heterotopia in the lung.

Authors:  Paulo Roberto Veiga Quemelo; Lourenço Sbragia; Luiz Cesar Peres
Journal:  Int J Exp Pathol       Date:  2007-10       Impact factor: 1.925

3.  Expression of neuronal antigens and related ventral and dorsal proteins in the normal spinal cord and a surgically induced open neural tube defect of the spine in chick embryos: an immunohistochemical study.

Authors:  Do-Hun Lee; Ji Hoon Phi; You-Nam Chung; Yun-Jin Lee; Seung-Ki Kim; Byung-Kyu Cho; Dong Won Kim; Moon-Sik Park; Kyu-Chang Wang
Journal:  Childs Nerv Syst       Date:  2009-12-01       Impact factor: 1.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.